Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of ...

Piramal's global Contract Development and Manufacturing Organization plans to more than double the facility’s capacity by Q1 ...

Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new lab, and ...

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma has unveiled an $80M investment plan to expand its Lexington, ...

Mumbai: Piramal Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA ...

GIFT Nifty ended 22 points or 0.08% down at 25,984.50 indicating a negative opening for domestic indices NSE Nifty 50 and BSE ...

Tata Consumer Products, Indian Railway Catering and Tourism Corporation, Andhra Cements, Zuari Industries, India Glycols, ...

Dopavision presented the primary 6-month clinical data from its proof-of-concept study of MyopiaX, a transformative approach that aims to control juvenile-onset myopia, on Friday, September 27th, 2024 ...

Broadway Licensing, the flagship musical imprint for the world's fastest growing theatrical licensing company, Broadway Licensing Global, which includes imprints Dramatists Play Service and ...